What Happened to Mark Cuban?

Mark Cuban, a self-made billionaire known for his ventures in technology, sports, and entertainment, has seen significant shifts in his portfolio and public focus in recent years, particularly leading up to and through 2026. His most notable recent move was the sale of his majority stake in the NBA's Dallas Mavericks. In December 2023, Cuban sold 73% of the team to Miriam Adelson and her family for an estimated $3.5 billion, though he retained a 27% minority stake and, crucially, control over basketball operations. This decision was partly driven by the Adelson family's interest in real estate development and the potential for a casino near a new arena, an area Cuban was not keen to invest in personally. However, by March 2026, Cuban publicly expressed regret over who he sold to, stating he made mistakes in the process.

Cuban's entrepreneurial energy has largely pivoted to the Mark Cuban Cost Plus Drug Company (MCCPDC), which he co-founded in 2022 with the mission to provide generic prescription drugs at transparent, significantly lower prices by bypassing traditional pharmacy benefit managers (PBMs). The company has seen rapid expansion and strategic partnerships in 2026. In April 2026, MCCPDC announced a collaboration with Humana's CenterWell Pharmacy to develop new end-to-end employer prescription solutions, aiming to cut employer healthcare costs. This was followed in May 2026 by a high-profile partnership with the Trump administration's TrumpRx.gov platform, integrating MCCPDC to expand access to over 600 generic medications and promote price transparency. Further, in January 2026, MCCPDC allied with Alchem Laboratories to develop essential medicine therapeutics using AI and machine learning for supply chain resiliency, and in March 2026, partnered with Bluesight and GraphiteRx to expand its reach into hospitals. Research published in May 2026 indicated that Cost Plus Drugs often offers lower prices than employer plan cost-sharing for drugs with higher copays. As of 2026, the company offers over 2,500 medications directly to consumers and more than 6,000 through its marketplace for healthcare facilities.

Beyond healthcare, Cuban remains a prolific investor with a keen eye on emerging technologies, particularly artificial intelligence. While he champions AI as a transformative force and has invested in numerous AI startups, he also maintains a pragmatic view, noting that "AI is stupid" in its current form but indispensable for businesses to remain competitive. His Mark Cuban Foundation is actively involved in democratizing AI education, expanding its partnership with DataCamp in January 2026 to provide free AI and data skills training to one million teachers and students worldwide. Interestingly, in January 2026, he also made an investment in Burwoodland, a live events company, which some analysts termed an "anti-AI" move, emphasizing the enduring value of human-centered experiences in an increasingly digital world. In June 2026, Cuban advised recent graduates to seek jobs in small businesses, arguing that AI will empower them to compete more effectively with larger corporations.

His involvement in sports also saw a new development in May 2026 when he acquired an ownership stake in the Brampton Honey Badgers of the Canadian Elite Basketball League, citing the growing talent pool in Canadian basketball. On the entertainment front, Cuban announced his departure from the popular reality show "Shark Tank" after its 16th season, which aired in 2025. As of June 2026, Cuban's net worth is estimated to be between $6 billion and $10.3 billion, reflecting his continued success across diverse ventures.